93 related articles for article (PubMed ID: 24450180)
1. Antistaphylococcal action of lacto- and bifidobacteria and interleukn-2.
Mokrozub VV; Lazarenko LM; Babenko LP; Shinkarenko LM; Demchenko OM; Spivak MY; Bila VV
Mikrobiol Z; 2013; 75(6):17-21. PubMed ID: 24450180
[TBL] [Abstract][Full Text] [Related]
2. The effect of lacto- and bifidobacteria compositions on the vaginal microflora in cases of intravaginal staphylococcosis.
Babenko LP; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MJ
Mikrobiol Z; 2012; 74(5):116-25. PubMed ID: 23120992
[TBL] [Abstract][Full Text] [Related]
3. The effect of Lacto- and Bifidobacteria in monoculture on the vaginal microflora in norm and in cases of intravaginal staphylococcosis.
Babenko LR; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MJ
Mikrobiol Z; 2013; 75(3):46-55. PubMed ID: 23866586
[TBL] [Abstract][Full Text] [Related]
4. Effect of probiotic strains of lacto- and bifidobacteria on the activity of macrophages and other parameters of immunity in cases of staphylococcosis.
Mokrozub VV; Lazarenko LM; Babenko LP; Shynkarenko-Sichel LM; Olevinska ZM; Timoshok NO; Pidgorskyi VS; Spivak MY
Mikrobiol Z; 2012; 74(6):90-8. PubMed ID: 23293832
[TBL] [Abstract][Full Text] [Related]
5. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Sikorska H; Smoragiewicz W
Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
[TBL] [Abstract][Full Text] [Related]
6. The effect of lacto- and bifidobacteria compositions on the vaginal microflora in cases of intravaginal staphylococcosis.
Babenko LP; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MY
Mikrobiol Z; 2012; 74(6):80-9. PubMed ID: 23293831
[TBL] [Abstract][Full Text] [Related]
7. Specific properties of probiotic strains: relevance and benefits for the host.
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Spivak MY
EPMA J; 2018 Jun; 9(2):205-223. PubMed ID: 29896319
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of probiotic effects of
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Demchenko OA; Nechypurenko OV; Spivak MY
EPMA J; 2017 Dec; 8(4):357-376. PubMed ID: 29209439
[TBL] [Abstract][Full Text] [Related]
9. The role of beneficial bacteria wall elasticity in regulating innate immune response.
Мokrozub VV; Lazarenko LM; Sichel LM; Babenko LP; Lytvyn PM; Demchenko OM; Melnichenko YO; Boyko NV; Biavati B; DiGioia D; Bubnov RV; Spivak MY
EPMA J; 2015; 6(1):13. PubMed ID: 26110044
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
11. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.
Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB
Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349
[TBL] [Abstract][Full Text] [Related]
12. Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.
Falalyeyeva TM; Leschenko IV; Beregova TV; Lazarenko LM; Savchuk OM; Sichel LM; Tsyryuk OI; Vovk TB; Spivak MY
Fiziol Zh (1994); 2017; 63(1):17-25. PubMed ID: 29975824
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.
D'Aimmo MR; Modesto M; Biavati B
Int J Food Microbiol; 2007 Apr; 115(1):35-42. PubMed ID: 17198739
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of media for selective enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and bifidobacteria.
Dave RI; Shah NP
J Dairy Sci; 1996 Sep; 79(9):1529-36. PubMed ID: 8899517
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
16. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
18. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
Candela M; Perna F; Carnevali P; Vitali B; Ciati R; Gionchetti P; Rizzello F; Campieri M; Brigidi P
Int J Food Microbiol; 2008 Jul; 125(3):286-92. PubMed ID: 18524406
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli.
Putaala H; Barrangou R; Leyer GJ; Ouwehand AC; Hansen EB; Romero DA; Rautonen N
Benef Microbes; 2010 Sep; 1(3):283-95. PubMed ID: 21831765
[TBL] [Abstract][Full Text] [Related]
20. Interactions among lactic acid starter and probiotic bacteria used for fermented dairy products.
Vinderola CG; Mocchiutti P; Reinheimer JA
J Dairy Sci; 2002 Apr; 85(4):721-9. PubMed ID: 12018416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
